Literature DB >> 24411993

Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery.

Kimberly Stephens1, Bruce A Cooper1, Claudia West1, Steven M Paul1, Christina R Baggott1, John D Merriman1, Anand Dhruva2, Kord M Kober1, Dale J Langford1, Heather Leutwyler1, Judith A Luce2, Brian L Schmidt3, Gary M Abrams2, Charles Elboim4, Deborah Hamolsky1, Jon D Levine5, Christine Miaskowski1, Bradley E Aouizerat6.   

Abstract

UNLABELLED: Persistent pain following breast cancer surgery is a significant clinical problem. Although immune mechanisms may play a role in the development and maintenance of persistent pain, few studies have evaluated for associations between persistent breast pain following breast cancer surgery and variations in cytokine genes. In this study, associations between previously identified extreme persistent breast pain phenotypes (ie, no pain vs severe pain) and single nucleotide polymorphisms (SNPs) spanning 15 cytokine genes were evaluated. In unadjusted analyses, the frequency of 13 SNPs and 3 haplotypes in 7 genes differed significantly between the no pain and severe pain classes. After adjustment for preoperative breast pain and the severity of average postoperative pain, 1 SNP (ie, interleukin [IL] 1 receptor 2 rs11674595) and 1 haplotype (ie, IL10 haplotype A8) were associated with pain group membership. These findings suggest a role for cytokine gene polymorphisms in the development of persistent breast pain following breast cancer surgery. PERSPECTIVE: This study evaluated for associations between cytokine gene variations and the severity of persistent breast pain in women following breast cancer surgery. Variations in 2 cytokine genes were associated with severe breast pain. The results suggest that cytokines play a role in the development of persistent postsurgical pain.
Copyright © 2014 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokines; breast cancer surgery; candidate genes; persistent pain; polymorphism

Mesh:

Substances:

Year:  2013        PMID: 24411993      PMCID: PMC4331184          DOI: 10.1016/j.jpain.2013.09.015

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  67 in total

1.  Control of confounding of genetic associations in stratified populations.

Authors:  Clive J Hoggart; Eteban J Parra; Mark D Shriver; Carolina Bonilla; Rick A Kittles; David G Clayton; Paul M McKeigue
Journal:  Am J Hum Genet       Date:  2003-06       Impact factor: 11.025

Review 2.  Neuropathic pain following breast cancer surgery: proposed classification and research update.

Authors:  Beth F Jung; Gretchen M Ahrendt; Anne Louise Oaklander; Robert H Dworkin
Journal:  Pain       Date:  2003-07       Impact factor: 6.961

3.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

4.  Postmastectomy/postlumpectomy pain in breast cancer survivors.

Authors:  J S Carpenter; M A Andrykowski; P Sloan; L Cunningham; M J Cordova; J L Studts; P C McGrath; D Sloan; D E Kenady
Journal:  J Clin Epidemiol       Date:  1998-12       Impact factor: 6.437

5.  Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer.

Authors:  J M Ververs; R M Roumen; A J Vingerhoets; G Vreugdenhil; J W Coebergh; M A Crommelin; E J Luiten; O J Repelaer van Driel; M Schijven; J C Wissing; A C Voogd
Journal:  Eur J Cancer       Date:  2001-05       Impact factor: 9.162

Review 6.  Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention.

Authors:  Kenneth Geving Andersen; Henrik Kehlet
Journal:  J Pain       Date:  2011-03-24       Impact factor: 5.820

7.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.

Authors:  F Colotta; F Re; M Muzio; R Bertini; N Polentarutti; M Sironi; J G Giri; S K Dower; J E Sims; A Mantovani
Journal:  Science       Date:  1993-07-23       Impact factor: 47.728

8.  GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization.

Authors:  Robert J Harvey; Ulrike B Depner; Heinz Wässle; Seifollah Ahmadi; Cornelia Heindl; Heiko Reinold; Trevor G Smart; Kirsten Harvey; Burkhard Schütz; Osama M Abo-Salem; Andreas Zimmer; Pierrick Poisbeau; Hans Welzl; David P Wolfer; Heinrich Betz; Hanns Ulrich Zeilhofer; Ulrike Müller
Journal:  Science       Date:  2004-05-07       Impact factor: 47.728

9.  Health status and quality of life among non-Hodgkin lymphoma survivors.

Authors:  Sophia K Smith; Sheryl Zimmerman; Christianna S Williams; Bradley J Zebrack
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

10.  Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study.

Authors:  Charles D MacLean; Benjamin Littenberg; Amanda G Kennedy
Journal:  BMC Fam Pract       Date:  2006-08-15       Impact factor: 2.497

View more
  24 in total

Review 1.  Genetic Variants Associated with Cancer Pain and Response to Opioid Analgesics: Implications for Precision Pain Management.

Authors:  Gee Su Yang; Natalie M Barnes; Debra E Lyon; Susan G Dorsey
Journal:  Semin Oncol Nurs       Date:  2019-05-10       Impact factor: 2.315

Review 2.  Systematic Review and Meta-Analysis of Genetic Risk of Developing Chronic Postsurgical Pain.

Authors:  Vidya Chidambaran; Yang Gang; Valentina Pilipenko; Maria Ashton; Lili Ding
Journal:  J Pain       Date:  2019-05-23       Impact factor: 5.820

3.  Cytokine Gene Polymorphisms Associated With Various Domains of Quality of Life in Women With Breast Cancer.

Authors:  Kimberly Alexander; Yvette P Conley; Jon D Levine; Bruce A Cooper; Steven M Paul; Judy Mastick; Claudia West; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2017-09-23       Impact factor: 3.612

4.  Chronic postsurgical pain: is there a possible genetic link?

Authors:  Sabu Kumar James
Journal:  Br J Pain       Date:  2017-07-28

5.  Variations in COMT and NTRK2 Influence Symptom Burden in Women Undergoing Breast Cancer Treatment.

Authors:  Erin E Young; Debra Lynch Kelly; Insop Shim; Kyle M Baumbauer; Angela Starkweather; Debra E Lyon
Journal:  Biol Res Nurs       Date:  2017-02-16       Impact factor: 2.522

6.  Polymorphisms in Cytokine Genes Are Associated With Higher Levels of Fatigue and Lower Levels of Energy in Women After Breast Cancer Surgery.

Authors:  Kord M Kober; Betty Smoot; Steven M Paul; Bruce A Cooper; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2016-09-21       Impact factor: 3.612

7.  Systematic review of genetic polymorphisms associated with psychoneurological symptoms in breast cancer survivors.

Authors:  Gee Su Yang; Sreelakshmy Kumar; Susan G Dorsey; Angela R Starkweather; Debra Lynch Kelly; Debra E Lyon
Journal:  Support Care Cancer       Date:  2018-10-20       Impact factor: 3.603

8.  Associations between genetic and epigenetic variations in cytokine genes and mild persistent breast pain in women following breast cancer surgery.

Authors:  Kimberly E Stephens; Jon D Levine; Bradley E Aouizerat; Steven M Paul; Gary Abrams; Yvette P Conley; Christine Miaskowski
Journal:  Cytokine       Date:  2017-07-29       Impact factor: 3.861

9.  Genetic Polymorphisms of Cytokines Might Affect Postoperative Sufentanil Dosage for Analgesia in Patients.

Authors:  Jian Guo; Fei Yuan; Yixin Yang; Yunze Li; Fangping Bao; Xuejiao Guo; Zhiying Feng
Journal:  J Pain Res       Date:  2020-06-16       Impact factor: 3.133

10.  Informative gene network for chemotherapy-induced peripheral neuropathy.

Authors:  Cielito C Reyes-Gibby; Jian Wang; Sai-Ching J Yeung; Sanjay Shete
Journal:  BioData Min       Date:  2015-08-12       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.